Study of STG-001 in Subjects With Stargardt Disease

Stargardt Disease

Function and Imaging Assessments for G1961E-associated Stargardt Disease Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects Lesion(s) in Adolescent Subjects With STGD1 Pupil Dynamics and Color Vision for the Detection of Eye Diseases Learning Study: Improving Vision in Adults With Macular Degeneration Oral Metformin for Treatment of ABCA4 Retinopathy Study of STG-001 in Subjects With Stargardt Disease Efficacy of Acupuncture in Macular Diseases Stem Cells Therapy in Degenerative Diseases of the Retina Rod and Cone Mediated Function in Retinal Disease Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases Phase 1 Safety Study of ALK-001 in Healthy Volunteers Microcurrent Stimulation to Treat Macular Degeneration Improving Vision in Adults With Macular Degeneration Stem Cell Ophthalmology Treatment Study A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt’s Macular Degeneration Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE) Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy Safety and Efficacy of Emixustat in Stargardt Disease Phase I/II Study of SAR422459 in Patients With Stargardt’s Macular Degeneration Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease